C07K 5/0804
And aliphatic
Official title: {and aliphatic}
C07K5/0804 (And aliphatic) appears on 1,382 US grants and 1,440 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,382
- Published applications
- 1,440
- Assignees
- 804
- Inventors
- 3,681
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 4 | 0 |
| 1978 | 10 | 0 |
| 1979 | 9 | 0 |
| 1980 | 13 | 0 |
| 1981 | 13 | 0 |
| 1982 | 10 | 0 |
| 1983 | 6 | 0 |
| 1984 | 18 | 0 |
| 1985 | 9 | 0 |
| 1986 | 11 | 0 |
| 1987 | 14 | 0 |
| 1988 | 10 | 0 |
| 1989 | 11 | 0 |
| 1990 | 8 | 0 |
| 1991 | 9 | 0 |
| 1992 | 16 | 0 |
| 1993 | 18 | 0 |
| 1994 | 12 | 0 |
| 1995 | 19 | 0 |
| 1996 | 29 | 0 |
| 1997 | 21 | 0 |
| 1998 | 45 | 0 |
| 1999 | 36 | 0 |
| 2000 | 56 | 0 |
| 2001 | 28 | 5 |
| 2002 | 26 | 33 |
| 2003 | 32 | 63 |
| 2004 | 19 | 54 |
| 2005 | 22 | 49 |
| 2006 | 39 | 52 |
| 2007 | 33 | 69 |
| 2008 | 29 | 68 |
| 2009 | 43 | 96 |
| 2010 | 46 | 68 |
| 2011 | 51 | 72 |
| 2012 | 49 | 66 |
| 2013 | 64 | 73 |
| 2014 | 58 | 77 |
| 2015 | 54 | 71 |
| 2016 | 75 | 55 |
| 2017 | 45 | 64 |
| 2018 | 43 | 52 |
| 2019 | 38 | 55 |
| 2020 | 31 | 43 |
| 2021 | 37 | 42 |
| 2022 | 25 | 51 |
| 2023 | 17 | 36 |
| 2024 | 26 | 55 |
| 2025 | 29 | 44 |
| 2026 | 11 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Peptide, cell growth promoter, protein production promoter, culture medium, cell growth method using peptide, and protein production method using peptide15 Sep 2026US 12,735,451 B2Maruhachi Muramatsu, Inc.
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Molecules18 Aug 2026US 12,709,596 B2Ena Respiratory Pty Ltd
- Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system23 Jun 2026US 12,661,412 B2University of Massachusetts
- Labyrinthin-based peptides for cancer immunotherapies and uses thereof16 Jun 2026US 12,655,184 B2LabyRx Immunologic Therapeutics (USA) Limited
- Macrocyclic broad spectrum antibiotics17 Sep 2026US 2026/0274892 A1Genentech, Inc.
- Peptide substrates and inhibitors of cathepsin b10 Sep 2026US 2026/0265298 A1The Regents of the University of California
- Production method for induced pluripotent stem cells27 Aug 2026US 2026/0250638 A1Sekisui Chemical Co., Ltd.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
- Cell membrane-penetrating peptide for conjugation20 Aug 2026US 2026/0242827 A1AGC Inc.
Most cited
By later US patents
- Antibody-therapeutic agent conjugates288US 4,867,973 ACytogen Corporation · 1989
- Methods for identifying RNA binding compounds220US 6,503,713 B1University of Medicine and Dentistry of New Jersey · 2003
- Peptide library and screening systems197US 5,432,018 AAffymax Technologies N.V. · 1995
- Boronic ester and acid compounds, synthesis and uses183US 6,083,903 ALeukoSite, Inc. · 2000
- Boronic ester and acid compounds175US 5,780,454 AProScript, Inc. · 1998